Delivery Order HHSN271201700020I-75N91023F00001
Award Date
9/15/23
Potential Completion Date
5/14/24
Potential Value
$79K
Federal Agency
National Cancer Institute
Awardee
Societal Cdmo San Diego, LLC
Ultimate Awardee
Recro Pharma, Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Societal CDMO San Diego, LLC, a small disadvantaged business contract development and manufacturing organization (CDMO). The $494,300 firm-fixed-price task order is for dosage form development, manufacture, and stability studies of the investigational compound metarrestin (ML246) under the larger "CRO Support for NCATS Drug Product Development,...
This $136,500 firm fixed-price delivery order was awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to Societal CDMO San Diego, LLC (doing business as Irisys Inc.). The contract is for the production of 2,500 vials of Cooper Histindinate, a pharmaceutical product likely used in cancer research and development. Societal CDMO San Diego is a small disadvantaged business contract development and manufacturing organization that...
This firm-fixed-price delivery order was awarded to Societal CDMO San Diego, LLC (a division of Recro Pharma, Inc.) by the National Cancer Institute, part of the National Institutes of Health at the Department of Health and Human Services. The $546,667.00 contract is for the production of an engineering batch, current Good Manufacturing Practice (cGMP) batch, delivery, and shelf-life study of ammonium tetrathiomolybdate (ATTM) capsules to support a clinical trial for a potential cancer...
The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $711,750.00 Firm Fixed Price Delivery Order contract to Societal CDMO San Diego, LLC (doing business as Irisys Inc.) for Metarrestin cGMP manufacturing and stability testing services. This contract is under the NCATS Drug Product Development Studies 2017-2022 indefinite delivery, indefinite quantity (IDIQ) contract vehicle. Societal CDMO is a self-certified small disadvantaged...
This is a delivery order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Societal Cdmo San Diego, LLC, a small disadvantaged business contract development and manufacturing organization (CDMO). The $505,500.00 contract is for the development and manufacture of a novobiocin capsule product, including a 36-month shelf-life study, in support of NIH's cancer research programs. The award is issued under the Drug Formulation...
This federal contract award, valued at $89,418.97, was issued by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS), to Societal Cdmo San Diego, LLC, doing business as Irisys Inc. Societal Cdmo San Diego is a small disadvantaged business that specializes in pharmaceutical product development, manufacturing, and testing services for the federal government. The contract is for "SPECIAL...
The National Cancer Institute (NCI) awarded a $73,009 cost-plus-fixed-fee delivery order to Societal CDMO San Diego, LLC, a self-certified small disadvantaged business doing business as Irisys Inc. The contract is for the production of 600 bottles of tetrahydrouridine powder, a compound used in cancer research. This order is part of Societal CDMO San Diego's multiple-award $45 million Drug Formulation and Manufacturing Contracts 2019 Indefinite Delivery Vehicle (IDV) with the National Institutes...
This is a federal contract awarded by the National Cancer Institute (NCI), an agency within the Department of Health and Human Services (HHS), to Societal Cdmo San Diego, LLC, doing business as Irisys Inc. The $132,775 cost-plus-fixed-fee contract is for the provision of special studies and analysis related to chemical and biological manufacturing. The contract has no set-aside designation. Societal Cdmo San Diego is a small disadvantaged business that provides pharmaceutical development,...
This federal contract award was issued by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Societal CDMO San Diego, LLC (doing business as Irisys Inc.), a self-certified small disadvantaged business and contract development and manufacturing organization (CDMO). The $77,283 task order is for the manufacture of 4-thio-2-deoxycytidine capsules, which are likely being developed for use in...
This is a $760,749 firm fixed-price delivery order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health, to Societal CDMO San Diego, LLC (doing business as Irisys Inc.). The order is to provide dosage form development, manufacturing, and stability studies of the investigational drug ORC-13661 for a Phase II clinical trial. This delivery order was issued under the NCATS Drug Product Development Studies 2017-2022 indefinite...